It is “conceivable” that the U.S. could begin to roll out a coronavirus vaccine by December, the White House’s top infectious disease expert said Friday. “Back in January of this year when we started the phase 1 trial, I said it would likely be...
AstraZeneca, South San Francisco, California, April 11, 2020. Smith Collection/Gado/Getty Images AstraZeneca has received more than $1 billion from the U.S. Health Department’s Biomedical Advanced Research and Development Authority (BARDA) to develop a...
Scientists in Singapore are developing a vaccine for the coronavirus, with hopes that early-stage clinical trials could come as soon as next month, according to a professor at Duke-NUS Medical School. Researchers at Duke-NUS Medical School are currently working on a...
Heavy hearts soared Monday with news that Moderna’s Covid-19 vaccine candidate — the frontrunner in the American market — seemed to be generating an immune response in Phase 1 trial subjects. The company’s stock valuation also surged, hitting $29 billion,...
World leaders are meeting virtually Monday at the World Health Organization’s 73rd World Health Assembly to discuss and set priorities for the next year. Chinese President Xi Jinping delivered remarks earlier this morning in which he announced $2 billion in...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
